Stay updated with breaking news from Avinger Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research note published on Sunday morning. The firm issued a hold rating on the medical device company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $5.00 target price on shares of Avinger in a report on Thursday, March 21st. […]
StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical device company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $5.00 price target on shares of Avinger in a research note on Thursday, March 21st. View […]
StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research report released on Saturday. The firm issued a hold rating on the medical device company’s stock. Separately, HC Wainwright restated a buy rating and set a $5.00 price target on shares of Avinger in a research note on Thursday, March 21st. […]
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of $11 million or approx...
Advances New OCT-Guided Coronary Product Development REDWOOD CITY, CA / ACCESSWIRE / May 15, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, to...